진매트릭스

본문 바로가기
Search

History

Take-off period (2016 – )

2017

· International distribution contract with AB ANALITICA ofItaly
· Exhibition at MEDICA, an international medical device exhibition in Germany
· Obtained the CE certification for Neoplex STI-7, Neoplex STI PLUS, Neoplex Viewer
· Selected as 2017 K-Brainpower (Ministry of Trade, Industry and Energy)
· Neoplex STI-7 MFDS certified
· Omniplex-HPV MFDS certified

2016

· International cooperation in commercialization with Luminex/USA · Joint research for the vaccine development of Zika virus (Korea Center for Disease Control and Prevention) · Applied for C-tag patent, the platform technology of multiplex molecular diagnostics

Progression period (2011 – 2015)

2015

· Exhibition at ‘Arab Health’, an international medical device exhibition in Dubai

2014

· Registered a new medical technology resistant to HBV entecavir
· Obtained the patent for a natural product-derived anticancer treatment
· Soo-ok Kim inaugurated as CEO

2013

· KFDA approval for 8 in-vitro diagnostic medical devices
· Obtained the CE certification for Papillotyper
· Development of HIV-specific therapeutic diagnostic agent

2012

· Entering the organic certification business
· Moved the head office (Korea Bio Park)

2011

· Acquired HBI, a venture company that specializes in diagnostic device
· Obtained ISO 13485 certification

Growth period (2000 – 2010)

2010

· Cross license agreement with Riversense, USA
· Received the Presidential commendation for venture company

2009

· Earned the RFMP certification (US 7,541,148)
· Listed on KOSDAQ

2008

· Capital increase (KB start-up investment)
· Publication in Nature Protocols
· Selected as a national new growth-engine industry

2007

· Confirmed for Innovation Business (Inno-Biz)
· Received the GSK Hepatitis Academic Award (Korean Association for the Study of the Liver)
· Received the Patent Grand Prize, King Sejong Award (Korean Intellectual Property Office)
· Capital increase (CKD start-up investment)

2006

· Capital increase (KT&G start-up investment)
· Awarded the Grand Prize at the Asian Pacific Association for the Study of the Liver
· Publication in Gastroenterology
· Publication in Gut
· Publication in Hepatology
· Organizing the international joint technology development project of the Ministry of Commerce Industry and Energy

2005

· Patent registered for RFMP technology in Korea (No. 477766)
· Organizing the Technology Innovation Development Project of the Ministry of SMEs (Diagnostic method for leukemia treatment resistance)
· Received the GSK Hepatitis Academic Award (Korean Association for the Study of the Liver)
· Selected as one of the Top 100 Successful Industrial Technology Development Projects
· Hosting the Satellite Symposium of the Asian Pacific Association for the Study of the Liver

2003

· RFMP Technology Licensing Out (Clinical Genotyping Technology)
· Organizing the joint core technology development projects of the Ministry of Commerce Industry and Energy (Virus molecular diagnostics)

2002

· Organizing the health and medical development projects of the Ministry of Health and Welfare
· Organizing the Common food technology development business of the Ministry of Commerce Industry and Energy
· Development of drug resistant viral genetic analysis for hepatitis therapy

2001

· Establishment of an affiliated research institute (within the Institute of Cancer Research, Seoul National University College of Medicine)
· Strategic alliance with Variagenics, USA (Development of Genetic Marker in Pathway of Drug Action)
· International research collaboration agreement with Los Alamos National Laboratory, USA (Development of soluble array)
· Certified as the venture business (New technology)
· Capital increase (Korea Development Bank, Korea Investment Trust Securities, Korea Technology Investment, KIBO Capital, IBK, Variagenics)

2000

Establishment of Genematrix, Inc.


Copyright 2018 © Genematrix Inc., All rights reserved.

Copyrights 2018 ⓒ Genematrix. co.ltd., All rights reserved.